Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period
Q4 2024 Management View CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ...
Applied Clinical Trials Online6d
Collaborative Strategies for Technology Integration in Clinical Studies
In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...
JD Supra3d
Navigating Clinical Research Agreements and Regulatory Strategy for Successful Commercialization
Clinical research agreements (CRAs) and developing a regulatory strategy—particularly in connection with the Food and Drug Administration ...
JD Supra7d
FDA, OHRP Issue Joint Guidance on Collection of Tissue Biopsies in Clinical Trials
On January 6, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) Office for Human ...
Medscape13d
Novel Accelerated Theta-Burst Stimulation Protocol Shows Promise for Treatment-Resistant Depression
A new accelerated theta-burst stimulation protocol may be a viable alternative to more intensive and costly neuromodulation ...